LEADER 04106nam  22005655  450 
001 9910410030403321
005 20200701090846.0
010   $a3-030-44790-1
024 7 $a10.1007/978-3-030-44790-8
035   $a(CKB)4100000011231651
035   $a(MiAaPQ)EBC6191804
035   $a(DE-He213)978-3-030-44790-8
035   $a(PPN)248395157
035   $a(EXLCZ)994100000011231651
100   $a20200506d2020      u|         0
101 0 $aeng
135   $aurcnu||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aInstitutional Corruption Theory in Pharmaceutical Industry-Medicine Relationships $eA Qualitative Analysis of Hungary and the Netherlands /$fby Anna Laskai
205   $a1st ed. 2020.
210  1$aCham :$cSpringer International Publishing :$cImprint: Springer,$d2020.
215   $a1 online resource (298 pages)
225 1 $aStudies of Organized Crime,$x1571-5493 ;$v19
311   $a3-030-44789-8 
327   $a1. Introduction -- 2. Industry Corruption of Medical Knowledge Production -- 3. Between Knowledge Production and Knowledge Interpretation -- 4. Interpreting Science into Practice: Institutional corruption of medical knowledge interpretation -- 5. Institutional Corruption of Medical Knowledge Application -- 6. Conclusion. -7. Appendix 1: Methodological audit trail -- 8. Appendix 2: Regulatory enumeration.
330   $aThis book discusses the influence of the pharmaceutical industry on the practice of medicine, and the observed and potential pitfalls of such partnerships. It argues that the pharmaceutical industry has become indispensable to many of the activities of the medical profession across the pharmaceutical product lifecycle, and examines the regulatory, ethical, professional and institutional difficulties that arise from these interactions. With data drawn from over 80 qualitative accounts from medical, pharmaceutical, regulatory and healthcare professionals, this book uses both Hungary and the Netherlands as case studies to demonstrate the potential problem of undue pharmaceutical industry influence within the relationships fostered with the profession of medicine. Chapters systematically describe the lifecycle of a pharmaceutical product from research to distribution, demonstrating the interdependency of industry and medicine. Arguing that the medical profession should be a buffer between the pharmaceutical industry interests and patient interests, the book explores how undue industry influence weakens the ability of the medical profession to do so. Using the theory of institutional corruption, the book aims to analyze how conflict of interest and the weakening of institutional imperatives is a result of institutional interactions rather than individual actions. Appropriate for students and researchers of the pharmaceutical industry, corporate corruption, and those working in NGOs and policy making, this unique volume is an comprehensive look at the complex relationship between medicine and pharmacy. .
410  0$aStudies of Organized Crime,$x1571-5493 ;$v19
606   $aCritical criminology
606   $aWhite collar crimes
606   $aOrganized crime
606   $aCritical Criminology$3https://scigraph.springernature.com/ontologies/product-market-codes/1B1000
606   $aWhite Collar Crime$3https://scigraph.springernature.com/ontologies/product-market-codes/1BD000
606   $aOrganized Crime$3https://scigraph.springernature.com/ontologies/product-market-codes/1B8000
615  0$aCritical criminology.
615  0$aWhite collar crimes.
615  0$aOrganized crime.
615 14$aCritical Criminology.
615 24$aWhite Collar Crime.
615 24$aOrganized Crime.
676   $a338.476151
700   $aLaskai$b Anna$4aut$4http://id.loc.gov/vocabulary/relators/aut$0877858
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910410030403321
996   $aInstitutional Corruption Theory in Pharmaceutical Industry-Medicine Relationships$91959983
997   $aUNINA